Cargando…
Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
BACKGROUND: The prognostic role of pretreatment modified Glasgow Prognostic Score (mGPS) in small cell lung cancer (SCLC) patients remains unclear now. METHODS: The PubMed, EMBASE, Web of Science, and CNKI electronic databases were searched up to December 14, 2022. The primary and secondary outcomes...
Autores principales: | Xie, Yulian, Li, Hongjun, Hu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637526/ https://www.ncbi.nlm.nih.gov/pubmed/37960803 http://dx.doi.org/10.1097/MD.0000000000035962 |
Ejemplares similares
-
Prognostic value of pretreatment anemia in patients with soft tissue sarcoma: A meta-analysis
por: Shi, Landa, et al.
Publicado: (2021) -
High pretreatment D-dimer level is an independent unfavorable prognostic factor of small cell lung cancer: A systematic review and meta-analysis
por: Deng, Han-Yu, et al.
Publicado: (2021) -
The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis
por: Wang, Yan, et al.
Publicado: (2019) -
Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017) -
Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)